The Chinese market for facial injectables will grow quickly over the forecast period due to the market's underpenetrated nature (compared to the US and European markets), and also because of the country's improving economy.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables in China, with market projections 10 years into the future.
Geographies Covered: DRG's analysis uses the following breakdown of regions in China:
Notes: *Market metrics for this breakout are not shown quantitatively.
Procedures and Products Covered: DRG's analysis uses the following breakdown of procedures and products:
Market Forecast Features: Based on primary research with industry professionals, DRG use its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).
Competitive Analysis: DRG provides a detailed analysis of the competitive landscape and market shares for leading competitors.